Cargando…
Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis
BACKGROUND: Autoimmune hepatitis (AIH) is a chronic liver disease of unknown aetiology and characterized by continuing hepatocellular inflammation and necrosis. Autoantibodies represent accessible markers to measure the adaptive immune responses in the clinical investigation. Protein microarrays hav...
Autores principales: | Mazzara, Saveria, Sinisi, Antonia, Cardaci, Angela, Rossi, Riccardo Lorenzo, Muratori, Luigi, Abrignani, Sergio, Bombaci, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573979/ https://www.ncbi.nlm.nih.gov/pubmed/26375394 http://dx.doi.org/10.1371/journal.pone.0137927 |
Ejemplares similares
-
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data
por: Mazzara, Saveria, et al.
Publicado: (2017) -
Biomarkers in community-acquired pneumonia: can we do better by using them correctly?
por: Ranzani, Otavio Tavares, et al.
Publicado: (2019) -
A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center
por: Franceschini, Tania, et al.
Publicado: (2021) -
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
por: Sambataro, Domenico, et al.
Publicado: (2020) -
Plasmablastic lymphoma: one or more tumors?
por: Pileri, Stefano A., et al.
Publicado: (2021)